Oxford / AstraZeneca to produce vaccine against …

Pharmaceutical AstraZeneca and the University of Oxford they announced that a new version of your vaccine “It will be available for the European autumn”, that is to say the Argentine spring. This vaccine would serve to fight the variant of the coronavirus first identified in South Africa.

It was Oxford University vaccination professor Sarah Gilbert who made the announcement in an interview with the British BBC and pointed out that the pharmaceutical company “is already working on the first part of the manufacturing process in Oxford”.

It will then “be passed on to other members of the manufacturing supply chain as we move forward,” he added, referring to the Oxford / AstraZeneca partners who produce the vaccines globally, like Argentina and Mexico in Latin America.

This new vaccine is not quite readysaid Gilbert, who clarified that “it is underway” and “is not yet ready to vaccinate people”.

According to a study published by the Financial Times, the vaccine currently produced by Oxford and AstraZeneca would be less effective against the South African variant of the virus and would not protect against mild or moderate symptoms.

“This year, we hope to show that the new version of the vaccine will generate antibodies that recognize the new variant. And then it will be a bit like working on the flu shot, so people will be familiar with the idea that we have to have new components, new strains in the influenza vaccine every year to keep up with the new strains that are circulating, ”they explained of the pharmaceutical company.